Unlock the Future of Drugs Discovery with AI: A Comprehensive to Molecular Design and Scalable AI.

The pharmaceutical industry is at a breaking point. With drug development costs exceeding $2 billion and success rates hovering below 10%, the traditional "trial and error" method is no longer sustainable. AI-Driven Drug Discovery and Manufacturing is the solution the industry has been waiting for. This course provides a complete, end-to-end blueprint for using Artificial Intelligence to revolutionize how we find, design, and produce life-saving medicines.

We begin by diving into the AlphaFold Revolution. You will learn how to leverage AlphaFold 3 to solve the protein-folding problem, predicting complex 3D structures and protein-protein interactions with unprecedented accuracy. From there, you will master Structure-Based Drug Design (SBDD), moving beyond simple docking to AI-enhanced scoring functions that predict binding affinity more reliably than ever before.

What sets this course apart is its holistic approach. We don't stop at discovery; we bridge the gap between the lab and the factory. You will explore:

• Generative AI: Using VAEs and GANs to "invent" novel molecules with optimized properties.

• Predictive ADMET: Reducing clinical failure by predicting toxicity and metabolism in silico.

• Case Studies: Real-world breakdowns of AI-designed drugs like Halicin and Rentosertib.

• AI in Manufacturing: Utilizing Machine Learning for Quality by Design (QbD) and optimizing the chemical synthesis of the Active Pharmaceutical Ingredient (API).

Whether you are a biologist looking to master computational tools, a data scientist pivoting into biotech, or a manufacturing professional optimizing formulations, this course provides the hands-on exercises and theoretical depth needed to excel in the "Self-Driving Lab" era.

Join us to gain the technical expertise required to shorten discovery timelines from years to months and play a pivotal role in the next generation of pharmacology.